Literature DB >> 11850807

Correlation of postoperative recurrence in hepatocellular carcinoma with demethylation of repetitive sequences.

Osamu Itano1, Masakazu Ueda, Kiyoshi Kikuchi, Osamu Hashimoto, Shigeo Hayatsu, Masaharu Kawaguchi, Hiroaki Seki, Kouichi Aiura, Masaki Kitajima.   

Abstract

Restriction landmark genomic scanning (RLGS) was utilized to identify novel genomic alterations in hepatocellular carcinoma (HCC). Thirty-one HCC samples were examined by RLGS. Two high intensity spots were common to several RLGS profiles of different HCCs. Nucleotide sequencing and homology search analysis showed that these spots represented repetitive sequences, Human tandem repeat sequence (Genbank, L09552) and centromeric NotI cluster (Genbank, Y10752). These intensified signals were attributable to the occurrence of demethylated areas in the recognition sequence of the NotI site of the corresponding fragments. The intensity of these spots in the RLGS profile reflects their degree of demethylation, which was significantly correlated with postoperative recurrence, even in patients regarded as belonging to the good prognosis group by conventional prognostic factors. Multivariate analysis showed that the intensities of the two spots retained independent prognostic value. This is a new type of predictive factor for HCC based on epigenetic changes in hepatocarcinogenesis, and in the future it is expected to be of great value in making preoperative diagnosis and selecting postoperative therapy.

Entities:  

Mesh:

Year:  2002        PMID: 11850807     DOI: 10.1038/sj.onc.1205124

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  Biological and clinical relevance of quantitative global methylation of repetitive DNA sequences in chronic lymphocytic leukemia.

Authors:  Sonia Fabris; Valentina Bollati; Luca Agnelli; Fortunato Morabito; Valeria Motta; Giovanna Cutrona; Serena Matis; Anna Grazia Recchia; Vincenzo Gigliotti; Massimo Gentile; Giorgio Lambertenghi Deliliers; Pier Alberto Bertazzi; Manlio Ferrarini; Antonino Neri; Andrea Baccarelli
Journal:  Epigenetics       Date:  2011-02-01       Impact factor: 4.528

Review 2.  Epigenetic diagnostics of cancer--the application of DNA methylation markers.

Authors:  Jaroslaw Paluszczak; Wanda Baer-Dubowska
Journal:  J Appl Genet       Date:  2006       Impact factor: 3.240

3.  Both hypomethylation and hypermethylation in a 0.2-kb region of a DNA repeat in cancer.

Authors:  Rie Nishiyama; Lixin Qi; Michelle Lacey; Melanie Ehrlich
Journal:  Mol Cancer Res       Date:  2005-11       Impact factor: 5.852

Review 4.  DNA hypomethylation in cancer cells.

Authors:  Melanie Ehrlich
Journal:  Epigenomics       Date:  2009-12       Impact factor: 4.778

5.  Foetal haemoglobin-blood cells (F-cells) as a feature of embryonic tumours (blastomas).

Authors:  M Wolk; J E Martin; M Nowicki
Journal:  Br J Cancer       Date:  2007-06-26       Impact factor: 7.640

6.  Quantification of Global DNA Methylation in Canine Mammary Gland Tumors via Immunostaining of 5-Methylcytosine: Histopathological and Clinical Correlations.

Authors:  Luiz Roberto Biondi; Marcello Vannucci Tedardi; Luciana Boffoni Gentile; Patricia Pereira Costa Chamas; Maria Lucia Zaidan Dagli
Journal:  Front Vet Sci       Date:  2021-02-25

7.  Genome‑wide DNA hypomethylation drives a more invasive pancreatic cancer phenotype and has predictive occult distant metastasis and prognosis potential.

Authors:  Yuhei Endo; Koichi Suzuki; Yasuaki Kimura; Sawako Tamaki; Hidetoshi Aizawa; Iku Abe; Fumiaki Watanabe; Takaharu Kato; Masaaki Saito; Kazushige Futsuhara; Hiroshi Noda; Fumio Konishi; Toshiki Rikiyama
Journal:  Int J Oncol       Date:  2022-04-08       Impact factor: 5.650

Review 8.  Overexpression of Cancer-Associated Genes via Epigenetic Derepression Mechanisms in Gynecologic Cancer.

Authors:  Hae Min Jeong; Mi Jeong Kwon; Young Kee Shin
Journal:  Front Oncol       Date:  2014-02-04       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.